Meta-analysis: VEGF receptor tyrosine-kinase inhibitors associated ... - HemOncToday Print
HemOncTodayIn addition, patients with renal-cell carcinoma who were treated with sorafenib had a higher incidence rate of all-grade bleeding compared with those with

... read more